BHI News Section Archives - Page 79 of 1219

News

REGISTER NOW – The 9th Annual BioHealth Capital Region Forum: A Week Away and a World of Opportunity

One week away from the 9th Annual BioHealth Capital Region Forum (https://bit.ly/BHCRForum2023), a cornerstone event for anyone involved in the…

AndySeptember 11, 2023

News

Adaptive Phage Therapeutics CEO Greg Merril and His Father’s Journey Highlighted in BBC StoryWorks’ Documentary, ‘Race Against Resistance’

The documentary-style film addresses the urgent global health crisis of antimicrobial resistance, which is causing widespread concern in the scientific…

AndySeptember 6, 2023

News

Seize Opportunities at the 6th Annual BioHealth Capital Region Investment Conference: Applications Due September 12th

Your Invitation to apply to a Key Investment Event in Rockville, Maryland Awaits There's still time if you haven't yet…

AndySeptember 5, 2023

News

Still Time to Register: Unlock Collaboration at the 9th Annual BioHealth Capital Region Forum

Your Invitation to a Pivotal BioHealth Event in Rockville, Maryland Awaits If you haven't yet marked your calendar for the…

AndySeptember 5, 2023

News

BIO Podcast Episode 87: The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab?

The horseshoe crab has endured for over 450 million years.In this episode we talk with three experts about how this…

AndySeptember 5, 2023

News

PM Live: GSK invests over $270m in vaccine manufacturing ahead of RSV vaccine launch

GSK has announced it is investing over £270m to build a new vaccine manufacturing facility at its Wavre campus in…

AndySeptember 5, 2023

News

VLP Therapeutics group announces 2nd closing of funding to develop cancer, infectious disease vaccines, establish investigational vaccine manufacturing facility

US-based biotech company VLP Therapeutics, Inc. (VLPT) and its Tokyo-based group company VLP Therapeutics Japan, Inc. (VLPT Japan) together announced…

AndySeptember 5, 2023

News

Rockville’s MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program

ROCKVILLE, MD, Sept. 05, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing, manufacturing and…

AndySeptember 5, 2023

News

Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO

Join us for an insightful episode of BioTalk as host Rich Bendis welcomes back Rachel King, the visionary CEO…

AndySeptember 4, 2023

BioTalk with Rich Bendis Podcast

Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO

Join us for an insightful episode of BioTalk as host Rich Bendis welcomes back Rachel King, the visionary CEO of…

AndySeptember 4, 2023

BHI News Section

REGISTER NOW – The 9th Annual BioHealth Capital Region Forum: A Week Away and a World of Opportunity

Adaptive Phage Therapeutics CEO Greg Merril and His Father’s Journey Highlighted in BBC StoryWorks’ Documentary, ‘Race Against Resistance’

Seize Opportunities at the 6th Annual BioHealth Capital Region Investment Conference: Applications Due September 12th

Still Time to Register: Unlock Collaboration at the 9th Annual BioHealth Capital Region Forum

BIO Podcast Episode 87: The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab?

PM Live: GSK invests over $270m in vaccine manufacturing ahead of RSV vaccine launch

VLP Therapeutics group announces 2nd closing of funding to develop cancer, infectious disease vaccines, establish investigational vaccine manufacturing facility

Rockville’s MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program

Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO

Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search